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Arteries are exposed to relentless pulsatile hemody-
namic loads, but via mechanical homeostasis they
tend to maintain near optimal structure, properties,
and function over long periods in maturity in health.
Numerous insults can compromise such homeostatic
tendencies, however, resulting in maladaptations or
disease. Chronic inflammation can be counted among
the detrimental insults experienced by arteries, yet
inflammation can also play important homeostatic
roles. In this paper, we present a new theoretical
model of complementary mechanobiological and
immunobiological control of vascular geometry and
composition, and thus properties and function. We
motivate and illustrate the model using data for aortic
remodeling in a common mouse model of induced
hypertension. Predictions match the available data
well, noting a need for increased data for further
parameter refinement. The overall approach and
conclusions are general, however, and help to unify
two previously disparate literatures, thus leading to
deeper insight into the separate and overlapping roles
of mechanobiology and immunobiology in vascular
health and disease.
1. Introduction
The concept of homeostasis was introduced by Walter
Cannon in the 1920s, extending the notion of a stable
c© The Authors. Published by the Royal Society under the terms of the
Creative Commons Attribution License http://creativecommons.org/licenses/












internal environment (mileu intérieur) put forth by Claude Bernard in the 1870s. Over the years,
homeostasis has come to be known as a fundamental biological and physiological process by
which a select quantity is regulated to remain, within a particular range, near a target value
that is often referred to as a set-point. This process is achieved via negative feedback and is
thought to promote stable, near optimal function. Two prime examples include regulation of
interstitial fluid pH, at a microscale, and regulation of core body temperature, at a macroscale.
Although metrics of continuum biomechanics such as mechanical stresses cannot be sensed
or regulated directly by cells [1], they have proven useful as easily calculated surrogates as
evidenced in the vasculature, for example, by the narrow range of stress calculated at focal
adhesions in fibroblasts and smooth muscle cells [2,3] as well as the robust regulation of time
averaged blood flow-induced wall shear stress at the endothelial surface [4,5] and regulation
of mean blood pressure-induced intramural stress [6,7], both within and across species. Hence,
mechanical homeostasis manifests across spatio-temporal scales in the vasculature [8]. Macroscale
mechano-regulation of an artery can be achieved over short periods by vasoregulation of caliber,
but over long periods must include turnover of extracellular matrix within potentially evolving
mechanical states. Such regulation occurs via altered gene expression that can change cell number
and phenotype as well as matrix composition and organization, often in direct response to the
sustained alterations in hemodynamic stimuli.
Whereas chemical, thermal, and mechanical homeostasis have long been appreciated, roles
played by inflammation in homeostasis have been recognized much more recently. It is now
clear, however, that resident macrophages can promote tissue homeostasis by clearing apoptotic
cells and cellular debris as well as by removing degraded or damaged matrix [9,10]. Importantly,
like all primary vascular cells – endothelial, smooth muscle, and fibroblasts – macrophages are
highly sensitive to changes in their mechanical environment [11,12], thus they too can contribute
directly to mechanical homeostasis. Although the immune system evolved to protect against life-
threatening pathological insults, including bacterial and viral, an emerging paradigm suggests
that inflammatory processes also engage when normal homeostatic processes are not sufficient to
restore conditions when perturbed from normal [13]. The term “para-inflammation” was coined
to delineate these supportive homeostatic functions from the primary protective functions of
inflammation [14]. Regardless of terminology, the key observation is that inflammatory cells can
come to the aid of tissue specific cells to promote homeostasis when the latter are unable to
respond sufficiently or quickly enough to recover from a perturbation. One caveat, however, is
that inflammatory cells, having priority because of their ability to defend against life-threatening
insults, can alter normal homeostatic parameters, including set-points and gains in the negative
feedback system, and thereby establish a new homeostatic state, compromise homeostasis
altogether, or even drive the tissue toward disease [15]. There is, therefore, a pressing need to
understand better both the complementary and contrasting roles of immuno-mechano-regulation
of tissue structure and function (Figure 1).
The importance of inflammation in the remodeling of elastic and muscular arteries was
demonstrated in 2008 in cases of sustained alterations in flow, with inflammation resolving
quickly following the homeostatic response [16,17]. Soon thereafter, it was shown that resident
macrophages play a key role in such remodeling [18], though many different types of
inflammatory cells can participate, some with layer specificity [19]. In this paper, we present a
new theoretical framework for modeling one aspect of mechanical stress-mediated inflammation
and its role in vascular homeostasis or its loss. The framework is motivated by prior findings but
informed directly by recent data on aortic remodeling collected in our laboratory for a common
mouse model of induced hypertension, which elevates blood pressure above normal values and
thereby perturbs intramural stresses from original set-points. We illustrate the utility of the model
by computing evolving changes in wall geometry, composition, and properties, emphasizing for
the first time the important consequences not only of inflammatory support versus supremacy
but also of consequences of smooth muscle cell phenotypic modulation. As it can be seen, the











aorta either adapts or maladapts in response to a sustained elevation in blood pressure that is
driven by a pro-inflammatory mediator.
2. Methods
(a) Computational model
We recently showed that a computational model of arterial growth and remodeling (G&R) that
includes mechano- and immuno-stimulated matrix turnover can capture salient biomechanical
features of the time-course of maladaptive remodeling of the thoracic aorta in both C57BL/6
and Apoe-/- (on a C57BL/6 background) mice infused with angiotensin II (AngII) for a period
of weeks [20,21]. Briefly, this constrained mixture model allows one to account for the evolution
of mass fractions, mechanical properties, deposition stretches, and rates of turnover of multiple
structurally significant constituents. Among the key equations are the mixture relation for the













where ρ is the wall mass density, mαΓR (τ)> 0 denotes the true rate of mass density production
per unit reference volume at G&R time τ , qαΓ (s, τ)∈ [0, 1] is the fraction of material produced
at time τ that survives to the current time s≥ τ , and Ŵα is the stored energy function; each
term is constituent- (α= 1, 2, ..., N , accounting mainly for the dominant structural constituents,
namely, elastic fibers, smooth muscle, and multiple families of collagen fibers) and layer- (Γ =




Γn(τ) (s) is the
right Cauchy–Green tensor where





is the constituent- and layer-specific deformation gradient, with n(τ) denoting potentially
evolving constituent-specific natural (stress-free) configurations, FΓ capturing mixture-level
deformations (at G&R time s or τ ) relative to a common reference configuration, and GαΓ (τ)
representing the “deposition stretch” at which the constituent is incorporated within each layer.
Based on prior successes in modeling vascular G&R, let the mass density production and survival
functions be governed constitutively by
















where kαΓ > 0 is a rate parameter that governs constituent removal via a first-order type of kinetic
decay, ραΓR is the associated referential mass density, and Υ
α
Γ > 0 is a function that stimulates mass
production at (ΥαΓ = 1), below (Υ
α
Γ < 1), or above (Υ
α
Γ > 1) basal levels. The (convolution integral






Γ (s, τ) dτ . (2.5)
Further constitutive assumptions include a stress-dependent rate parameter for constituent
removal, assumed to take the form




1 + (∆σ (t))2
)
(2.6)
where kαΓ0 denotes a basal rate of removal (noting that both increases and decreases in stress
relative to its homeostatic set-point can hasten constituent removal, modeled phenomenologically
here given our current imprecise understanding of the complexities associated with stress











vulnerability of the matrix to the protease) as well as an immuno-mechano-stimulus function
for constituent production of the form
ΥαΓ (τ) = 1 + f
α
Γσ (∆σ (τ))− f
α
Γτw (∆τw (τ)) + f
α
Γ%ϕ (∆%ϕ (τ)) (2.7)
where∆σ= (σ − σo) /σo and∆τw = (τw − τwo) /τwo are normalized deviations in pressure- and
axial force-induced intramural stress σ and flow-induced wall shear stress τw from homeostatic
values (σo and τwo, respectively, each scalar metrics), and ∆%ϕ = ρRϕ/ρRϕmax ∈ [0, 1] is an
inflammatory cell fraction relative to its maximum possible referential density ρRϕmax (cf. Figure




Γ%ϕ generally nonlinear, monotonically increasing functions
such that fαΓη (0) = 0 for η= σ, τw, %ϕ, with linear approximations performing well under modest
perturbations. Importantly, these three quantities are wall (∆σ and ∆%ϕ) or luminal (∆τw)
averages, with the constituent- and layer-specific functions fαΓη (or their gain-type parameters,
if linearized) modulating respective changes in cell/matrix production rate within each layer.
Also following our prior study [20], let the intramural elastic fibers, smooth muscle, and
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(2.8)













for a circumferentially oriented composite of collagen fibers and passive smooth muscle
(α=m) plus axially and diagonally oriented collagen fibers (α= c) in the media as well as
circumferentially, axially, and diagonally oriented collagen fibers in the adventitia, with cα1 (∆%ϕ)
and cα2 (∆%ϕ) possibly inflammation-dependent material parameters (noting that inflammation
may override homeostatic set-points, alter the turnover of these constituents by altering gains for
production and rates of removal, and modify the mechanical properties of the newly produced
constituents) and λαn(τ)(s) the corresponding stretch. Together, these functions constitute a layer-
specific “four-fiber family” model, with effects of other constituents (such as proteoglycans) and








Γ (s, τ) σ̂
α
Γ (s, τ) dτ (2.10)
derives from the stored energy in Eq. (2.1), with









where mαΓ (τ) =m
α
ΓR (τ) /JΓ (τ) and J
α
Γn(τ) (s) = detF
α
Γn(τ) (s) = JΓ (s) /JΓ (τ), with JΓ =
detFΓ =
∑
ραΓR/ρ. Finally, consider an active stress contribution in the medial layer in the
circumferential direction [23]















where φmM = ρ
m
M/ρ is the spatial mass fraction, λθ,act the active circumferential stretch, Tmax the
basal tone, λM and λ0 levels of stretch at which contraction is maximal or minimal, and CB and
CS vasoactive parameters that regulate the contractile response via the flow-induced wall shear
stress. The circumferential stretch λθ,act (s) = a (s) /aact (s), with a (s) the current luminal radius

















with kact the associated rate parameter. In particular, aact (0) = a (0) (i.e., λθ,act (0) = 1) and
aact (s 0)→ a (s 0) (i.e., λθ,act (s 0)→ 1) when active remodeling is complete. Additional
details regarding the G&R model development and implementation can be found elsewhere [20].
(b) Stress-mediated inflammation
The convolution integral-based framework has proven useful because the mechanical
contributions and rates of removal of some constituents can depend on the time at which
they were incorporated within the extant matrix. Nevertheless, rate-based formulations offer
advantages in other situations, as, for example, when examining mechanobiological stability
[25,26]. Here, it proves useful constitutively to consider a rate-based approach. Differentiation
of Eq. (2.5) with respect to G&R time s yields the mass balance relation for constituent α written












which states that the rate of change of referential mass density (ρ̇αΓR) is given by the (im)balance













Γ − 1), which is an evolution
equation in rate form (cf. Eq. (2.5) in integral form) that describes well the mass turnover of
load-bearing constituents within the arterial wall via the immuno-mechano-mediated stimulus
function ΥαΓ in Eq. (2.7).
The wall stress-mediated evolution of inflammatory cell density may be described by an
evolution equation (or mass balance relation per unit reference volume), analogous to Eq. (2.14),
ρ̇Rϕ (s) =mRϕ (s)− nRϕ (s) (2.15)
aimed to capture the infiltration/activation or loss of inflammatory cells. In particular, we assume
that there are no active inflammatory cells at the onset of hypertension (ρRϕ (s= 0) = 0; cf. [22]).
Once present, subsequent removal is again described by first order kinetics, hence the rate of loss
is given by nRϕ = kϕρRϕ with kϕ an associated rate parameter (cf. [27]). With a normalized rate
of infiltration/activation µϕ =mRϕ/ρRϕmax, yet to be prescribed constitutively, Eq. (2.15) reads
∆%̇ϕ (s) = µϕ (s)− kϕ∆%ϕ (s) (2.16)
which, considering the initial condition ∆%ϕ (s= 0) = 0, admits a similar (convolution) solution




µϕ (τ) qϕ (s, τ) dτ (2.17)
with a survival function qϕ (s, τ) = exp (−kϕ(s− τ)) ∀τ ∈ [0, s]. Consistent with [13] and [15], we
now delineate two inflammatory responses that play different roles in homeostasis or its loss.
(i) Adaptive response
To let inflammation engage during normal adaptations that promote tissue homeostasis and help
to restore conditions when perturbed from normal [13,19], consider µϕ (τ) = kϕΥϕ (τ), where
Υϕ (τ) =Kϕ 〈∆σ (τ)〉 ≥ 0 is a stimulus function for inflammatory cell infiltration, with Kϕ an
associated non-dimensional gain while the Macaulay brackets 〈·〉 ensure that µϕ (τ)≥ 0 ∀τ and,
hence, ∆%ϕ (s)≥ 0 ∀s in Eq. (2.17). A value ∆%ϕ (s)∈ [0, 1], known from Eq. (2.17) at the current
G&R time s, enters the stimulus functions for smooth muscle and collagen production in Eq. (2.7),











of stresses to normal, along with the resolution of infiltration/activation rate µϕ(∆σ), lead to an
evolved mechano-adaptive homeostatic state.
(ii) Maladaptive response
Remarkably different characteristics manifest when inflammatory cells compromise homeostasis
or drive the tissue toward disease. In particular, the onset of inflammation is typically delayed
with respect to the mechano-adaptation [22], with the inflammatory response remaining “locked-
in” for a certain period after the remodeling may be regarded complete [21]. In the present
case of hypertension-induced aortic remodeling, the vessel can initially respond to an increase
in pressure-induced wall stress by an (adaptive) mechano-driven mass turnover (as described
in Section 2(b) i) that tries to restore the stress to normal and, only subsequently, an additional
overriding inflammatory response arises (presumably) due to persistently high stresses, with
inflammation remaining even if the stresses fall below normal during the (maladaptive)
remodeling process; from a biological perspective, this secondary inflammatory response may
relate to stress-mediated matrix damage or degradation, with persistent matrix fragments (e.g.,
exposed matricryptic sites) or altered matrix appearing as embedded neoantigens stimulating
inflammatory activity [28]. Thus, for the rate of production (infiltration/activation), we assume
that the inflammatory response promoting maladaptation is triggered only when the stress
reaches a certain threshold [15]. Importantly, these combined features are not captured well
with a mass production term that is proportional to a stress-dependent stimulus function (e.g.,
Υϕ =Kϕ 〈∆σ〉), but demand a new approach for the rate of change of inflammation.
(iii) Combined response
Thus, let µϕ (τ)≥ 0 be described by
µϕ (τ) = kϕKϕ 〈∆σ (τ)〉 if σ (τ̄)<σ∗ ∀τ̄ ≤ τ , (2.18)
dµϕ (τ)
dτ
= µ̄+ϕ if σ (τ)≥ σ∗ , (2.19)
dµϕ (τ)
dτ
=−µ̄−ϕ if σ (τ)<σ∗ and ∃τ̄ < τ | σ (τ̄)≥ σ∗ , (2.20)
where dµϕ (τ) /dτ = 0 otherwise and we delimit µϕ (τ)∈ [0, kϕ] ∀τ . Here, µ̄+ϕ > 0 and µ̄−ϕ > 0
are constants and σ∗ is a (scalar metric of) stress threshold above which inflammatory cells
infiltrate/activate during the maladaptive response; these parameters can be estimated from
a measured time course for the inflammatory response and biaxial stresses, the latter relative
to homeostatic set-points. The upper bound for µϕ(→ kϕ) defines a saturation value which, if
persistent, would eventually lead to a saturation value for the normalized-to-maximum density
∆%ϕ (→ 1) via Eq. (2.17); that is, with maximal infiltration µϕ (= kϕ) being precisely offset by
maximal removal kϕ∆%ϕmax (= kϕ) in Eq. (2.16). Importantly, inflammatory cell activity persists
as long as µϕ > 0, even if σ drops below σ∗, though with decreasing intensity described by
Eq. (2.20). Note that if σ does not reach the inflammatory threshold σ∗, then µϕ contributes
to an adaptive immuno-mechano-mediated remodeling via Eq. (2.18), as in some cases of
hypertension [29]. In general, a value ∆%ϕ (s)∈ [0, 1], known from Eq. (2.17) at the current G&R
time s, enters the stimulus functions for smooth muscle and collagen production in Eq. (2.7) and
simultaneously modifies their inflammation-dependent passive properties in Eq. (2.9) [20,21],
resulting in a coupled stress-driven immuno-mechanobiological response. Figure 2 (panel A)
shows, schematically, how these coupled effects of stress and inflammation are integrated into
the G&R model. In addition, panel B shows that transitions among the mild adaptive (period I),
acute maladaptive (II), saturated (III), and slow clearance (IV) inflammatory responses described
by Eqs. (2.18)-(2.20) generally imply instantaneous changes in dµϕ(τ)/dτ , with both µϕ(τ) and
∆%ϕ(s) in Eq. (2.17) evolving continuously (the latter also smoothly) over time. Finally, by virtue











of biaxial stresses σ (τ ≤ s), or, in other words, there is not a one-to-one relationship between
inflammation and stress, which will have important implications as noted below.
(c) Parameter estimation
In our previous studies [20,21], the time course of inflammatory cell density in Eq. (2.7)
was prescribed based on experimental findings (CD45+ staining). We emphasize here that
there remains a need for better time-course data, particularly at early times following the
perturbation in loading. Nevertheless, a key outcome of many G&R simulations of this type
is correct prediction of long-term behaviors, which in mouse models of altered hemodynamics
is typically after about two weeks. Here we use data available from a particular study [30,31]
and model the inflammatory history constitutively in Eq. (2.17) along with (2.18)-(2.20), which
requires additional determination of the parameters σ∗, Kϕ, kϕ, µ̄+ϕ , and µ̄−ϕ . The remaining
parameters in the model can be determined directly from experimental measurements (e.g.,
initial wall geometry, mass fractions, and in vivo state of stress and strain), nonlinear regressions
from consistent biaxial mechanical data, and estimations based on immunomechanobiologically
equilibrated evolutions over the course of AngII infusion; see Appendix in [20].
Here, σ∗ may be estimated as the value of σ at the onset of the maladaptive inflammatory
response. Let τ1 be the G&R time at which σ (τ1) = σ∗ >σo, with σ generally increasing
subsequently (see Figure 2, panel B, for definitions of time points). The stress σ will remain
greater than σ∗ over some period but will eventually equal σ∗ again (at τ3), and keep decreasing,
consistent with the immuno-mechano-mediated turnover. Assume that the period for which
σ > σ∗ persists is long enough such that the increasing inflammation rate saturates at µϕ = kϕ
(at τ2 ≤ τ3). Hence, neglecting an early, much milder increase in inflammation via Eq. (2.18) at
time τ1, we find, from Eq. (2.19)
dµϕ (τ)
dτ




= 0 =⇒ µϕ (τ) = µ̄+ϕ (τ2 − τ1)≡ kϕ for τ ∈ [τ2, τ3] , (2.22)
and from Eq. (2.20)
dµϕ (τ)
dτ
=−µ̄−ϕ =⇒ µϕ (τ) = kϕ − µ̄−ϕ (τ − τ3) for τ > τ3 (2.23)
Interestingly, consideration of this piecewise approximate solution for µϕ (τ) renders Eq. (2.17)







































































for s > τ3 (2.26)
Note: if µ̄−ϕ = 0, then ∆%ϕ approaches 1 (or µ̄+ϕ (τ3 − τ1) /kϕ if µϕ <kϕ at τ3) for s τ3,
and remains locked-in regardless of the maladaptive stress drop. Conversely, if µ̄−ϕ > 0, then
∆%ϕ reaches a maximum value . 1 (or . µ̄+ϕ (τ3 − τ1) /kϕ if µϕ <kϕ at τ3) and subsequently
decreases. In that case, Eqs. (2.24)-(2.26) allow the parameters kϕ, µ̄+ϕ , and µ̄−ϕ to be determined
from a time course for the inflammatory response (e.g., given particular values for the early rate
of change of ∆%ϕ (s), a potential peak ∆%ϕmax, and a long-term “remnant” value ∆%ϕ (s τ3)).
Finally, the gain Kϕ can be estimated based on the modest increase in inflammation ∆%ϕ (s < τ1)
prior to the onset of the maladaptive response.
(d) Coupling methodology
Equations (2.5) and (2.10) for the evolving mass density and stress of load-bearing constituents,
along with Eqs. (2.3) and (2.7) for their mass production, Eqs. (2.4) and (2.6) for their removal,
and Eqs. (2.8) and (2.9) for their passive response, are now coupled with Eqs. (2.17)-(2.20) for
the evolving inflammatory activity through the stimulus function in Eq. (2.7) along with the
possible presence of inflammation-dependent properties in Eq. (2.9) (see Supplemental Figure
S1 for an extended schematic representation that includes all the model equations and their
couplings). Hence, at each G&R time step, the following algorithmic implementation can ensure
simultaneous satisfaction of these equations before advancing to the next G&R time step:
I. With constituent stresses given by Eqs. (2.10) and mass (density) fractions from Eqs. (2.5),
enforce mechanical equilibrium under current internal pressure and axial stretch, with
fixed medial and adventitial Jacobians JΓ , to compute the vessel geometry and biaxial
stresses at the current time s.
II. Compute and store the inflammatory cell infiltration µϕ (τ = s) via Eqs. (2.18)-(2.20),
whose past history µϕ(τ < s) is needed to subsequently compute the current value for
∆%ϕ (s) via Eq. (2.17).
III. Update inflammation-dependent elastic parameters for collagen fibers and smooth
muscle cells in Eq. (2.9).
IV. Update rate parameters (2.6) and stimulus functions (2.7) to compute mass removal (2.4)
and production (2.3) using mass densities from the previous iteration.




VI. Repeat from step (I) with updated variables until the error between iterative mass
densities is lower than a prescribed tolerance.
This iterative procedure converges to the exact (implicit) solution at the current G&R time s
after few iterations. The integration scheme becomes explicit if one stops at step (V) and proceeds












According to the present modeling approach, a marked (chronic) increase in ∆%ϕ via Eq. (2.16)
requires an early increase in the cell infiltration rate µϕ via Eq. (2.19) which in turn requires the
stress σ to remain above the threshold σ∗ for a certain period (of the order of days to weeks).
Hence, the higher and more persistent the stress at the tissue level, the greater the inflammation.
Therefore, effects that reduce the magnitude and/or duration of a peak in the in-plane biaxial
stresses (as, for example, experienced early in hypertension-induced protocols) could reduce the
extent of inflammation and whether it promotes or prevents mechanical homeostasis at the tissue
level.
(a) Increase in blood pressure
In this example we verify and validate the present coupled formulation by reproducing previous
experimental [31] and computational [20] results on early hypertension-induced remodeling of
the aorta of male wild-type (C57BL/6) mice that focused on changes in the passive mechanical
behavior induced by changes in extracellular matrix. Consideration of different temporal
profiles for pressure elevation allows us to predict additional results enabled by the novel
coupling between stress and inflammation proposed herein. Geometrical, mechanical, and G&R
parameters are taken from [20] without modification, see Table 1. Consistent with the 4-week
(discrete) time course of the study and the biaxial stresses reported in [31], we estimate σ∗ ≡ σ∗v =
170 kPa (with σ≡ σv = (trσ)/3 = (σ : I)/3 the volumetric stress),Kϕ = 2.5, kϕ = 2/7 days−1, and
µ̄+ϕ = 0.102 days−2, with the (long-term) parameter µ̄−ϕ = 0, see Section 2(c). Eqs. (2.17)-(2.20)
for the evolving inflammation can then be integrated numerically while advancing the coupled
simulations, here with a time step ∆s= (1/kϕ)/10 = 0.35 days and a relative error tolerance of
10−9, see Section 2(d).
Figure 3 shows predictions of the present coupled model for a prescribed 1.36-fold increase
in systolic pressure achieved over a period of 7 days and maintained to 28 days (panel A, solid
lines), as in [20] based on experimental measurements. This rapid increase in pressure provokes
a relatively high early increase in circumferential (I) and axial (J) stresses that induce an, herein
computed, inflammatory response that eventually reaches the maximum value ∆%ϕmax = 1 (L),
consistent with the prior experimental observations. To illustrate the coupling between stress and
inflammation within the present approach, panel K shows how evolution of the mean volumetric
stress σ≡ σv >σ∗v stimulates a rapid increase in the inflammatory term µϕ via Eq. (2.19) that
subsequently triggers ∆%ϕ via Eq. (2.17), adversely affecting the remodeling. Indeed, note the
highly maladaptive response, with intramural stresses much lower than normal after two weeks
of AngII infusion, consistent with an excessive adventitial thickening (H, compare to medial
thickening, D) caused by fibrosis in the adventitia (F, G, compare to medial smooth muscle
hyperplasia/hypertrophy, B, C; [31]), with a mild decrease in luminal radius (E). Noting that
slower increases in pressure up to the same hypertensive systolic pressure would decrease the
peak for intramural stresses (because the tissue can effectively respond / remodel faster relative
to the stimulation timescale, cf. [24]), we progressively extended in silico the period over which
the pressure increases from 7 to 21 days. Predictions for these increasing periods (7, 14, 18, and
21 days to reach the 1.36-fold increase in pressure) show how slower hypertensive progression
results in a reduced maximal intramural stress σv and associated reduced maximal induced
inflammation ∆%ϕ(s= 28 days), thus allowing progressively better mechano-adaptations with
reduced adventitial fibrosis and hence thickening. In particular, for the slowest simulated
increase in pressure, achieved over 21 days (dotted lines), intramural stresses do not reach
the inflammatory threshold stress, and the model predicts an adaptive, both immuno- and
mechano-mediated, remodeling response to the same level of hypertension. Consistent with
Eq. (2.18), a modest inflammatory response, stimulated by a modest increase in biaxial stresses,
arises during the adaptation, hence supporting a mechanical homeostasis through an additional











homeostatic ranges (K, L, dotted lines; note that inner radius, hence shear stress stimulus for
constant cardiac output, also returns to normal, E). Indeed, albeit not shown, deactivation of this
initially supportive immuno-driven turnover (i.e., with Kϕ = 0 in Eq. (2.18)) for the simulation
with the slowest increase in pressure predicts a slower remodeling (relative to Kϕ = 2.5) with
∆%ϕ = 0 initially, whereby stresses slightly higher than the threshold for a short period result in a
modest maladaptive response.
(b) Increase in contractility
Experimental findings demonstrate an important role of smooth muscle mediated vasomotor
control of vessel lumen in flow-induced remodeling [7,16], and it appears that contractility plays
a similarly important role in hypertensive remodeling [22,32]. Nevertheless, the precise role of
contractility in hypertensive aortic remodeling remains unclear due in part to lack of information
on the basal tone in vivo and to what degree tone changes in hypertension. In this example we
explore, in silico, the effects of different levels of smooth muscle contractility added to the passive
response considered in the previous example. For illustrative purposes, we let Tmax = 258 kPa,
λM = 1.1, λ0 = 0.6, CB = 0.833, CS = 1.666, and kact = 1/7 days
−1 in Eqs. (2.12) and (2.13) (Table
1, cf. [24,33]). All remaining parameters remain the same as in Example 3(a).
Importantly, given an in vivo systolic pressure, inclusion of this additional contribution
to the total stress σ modifies the homeostatic state from which subsequent G&R simulations
should be initiated (consistent with initially equilibrated stimulus functions ΥαΓ = 1 in Eq. (2.7)).
In particular, basal smooth muscle contraction reduces inner radius and increases medial and
adventitial thicknesses, with circumferential and axial stress decreasing from σ(pas)θθo = 231 kPa
and σ(pas)zzo = 258 kPa (see G&R time s= 0 in Figure 3) to σθθo = 205 kPa and σzzo = 207 kPa.
Despite a lack of additional experimental data for the subsequent remodeling under constant
pressure, this contracted state is assumed herein for illustrative purposes to correspond to a
homeostatic state that enables subsequent G&R simulations to include both passive and active
contributions to stress from G&R time s= 0. Starting from this state, we let the pressure increase
over 7 days to the level that caused maximal inflammation in the previous example (solid
lines in Figure 3), which in this case resulted in a peak (passive plus active) stress σvmax =
155 kPa< 170 kPa = σ∗v at day 5, and, therefore, did not trigger a chronic inflammatory response
and associated maladaptation; that is, the remodeling led to an adaptive immuno-mechano-
adaptation.
Although a protective role of contractility was expected since it reduces the intramural stress
state [22,32], consider now a (fictitious) reference simulation for which an increase in pressure
over 7 days causes maximal inflammation when both passive and (baseline) active contributions
to stress are considered from the onset of hypertension, for which we consider a reduced
inflammatory stress threshold σ∗v = 150 kPa< 170 kPa. Since σvmax = 155 kPa> 150 kPa = σ∗v ,
this numerical experiment allows us to explore in silico the potentially protective role of an active
tone. Moreover, to consider the possibility that contractile strength could increase in hypertension
(e.g., smooth muscle hypertrophy), consider an increase up to AngII hypertension-appropriate
levels to overcome potentially emerging, adverse, inflammatory effects (cf. [34]). To facilitate
comparisons relative to a common baseline contracted state, let Tmax in Eq. (2.12) increase with
the extent of hypertension as Tmax (s) = Tmax (0) (1 +KP (P (s)− P (0))/P (0)), with KP a gain
parameter, with Tmax (0) = 258 kPa as in the prior example. Figure 4 shows predictions for a 1.36-
fold increase in systolic pressure over 7 days (A) for KP = 0 (i.e., Tmax (s) = Tmax (0) = 258 kPa
remains constant; solid lines), for which an early increase in stress σv >σ∗v (K) induces an
inflammatory response that approaches the maximum value ∆%ϕmax = 1 (L). Similar to the case
where only passive stresses were considered (cf. solid lines in Figure 3), a highly maladaptive
response (with low intramural stresses, I, J, consistent with an excessive adventitial thickening,
H, mainly caused by an aberrant deposition of collagen in the adventitia, F, G) emerges, which











role of contractility and strengthens the idea of its overriding role in disease progression
[15]. Simulations with higher values for the hypertensive gain parameter KP predict gradual
reductions in the maximal intramural stress σv and associated maximal induced inflammation
∆%ϕ(s= 28 days), suggesting a potentially (pre-emptively) protective role of heightened smooth
muscle contractility, with enhanced contractile responses preventing the vessel from experiencing
high stresses that can trigger an adverse inflammatory response. In particular, for the highest
regulation of tone considered, KP = 4 (dotted lines), the mean intramural stress σv did not
reach the inflammatory threshold σ∗v and the model predicted an adaptive, immuno-mechano-
mediated remodeling response, with an early increase in inflammation reversed during the
subsequent adaptation to the same level of hypertension. Importantly, note that the prescribed
increase in pressure combined with increasing contractile properties resulted in increasing
peaks of circumferential stress σθθ during an early remodeling stage, hence suggesting that σθθ
alone would not be a good metric for the present G&R model with stress-driven inflammation
and highlighting, in turn, the importance of considering a metric (e.g., σv) that assesses the
biaxial nature of the tensional state in the arterial wall. Nevertheless, there is a need for more
experimental information on the potential role of axial stress in arterial remodeling.
(c) Persistent long-term inflammatory response
Our immuno-mechanical aortic modeling [21] of atheroprone mice subjected to AngII-induced
hypertension for 28 days followed by 7 months of recovery without AngII infusion [22] predicted
that inflammation persisted, in part, for long periods after removing the exogenous AngII
stimulus. A subsequent re-evaluation of experimental data confirmed this prediction. This partial
reversal of the (maladaptive) inflammatory response can be described within the present coupled
model by considering the long-term parameter µ̄−ϕ > 0 in Eq. (2.20). In particular, similar to the
computational prediction, and experimental verification, assume that a remnant inflammatory
cell density∆%ϕ ≈ 0.4 remains at day 224 following the 28 days of induced hypertension. Indeed,
with all requisite values known from the reference simulation in Example 3(a) (τ1 ≈ 2 days,
τ2 ≈ τ3 ≈ 5 days, kϕ = 2/7 days−1, and µ̄+ϕ = 0.102 days−2), Eq. (2.26), with∆%ϕ(s= 224 days)≈
0.4 suggests a value µ̄−ϕ ≈ 0.0008 days−2, which we then prescribed as an input parameter to
our coupled model. Also motivated by experimental observations in [22], we prescribed a slow
decrease in systolic pressure to P/Po = 1.15 (down from a maximal 1.36 in [20], similar to the
decrease to 1.26 from a maximal 1.68 in [21]).
Figure 5 (solid lines) extends the results predicted in Figure 3 (solid lines) for wild-type
(C57BL/6) mice up to 224 days, with the model predicting a linear decrease in inflammation
from its maximal value at day 28 to the “experimental” value 0.4 at day 224 (L). Due to the lower
inflammation and reduced pressure (A), medial (D), but especially adventitial (H), thickening
(hence stresses, I, J) are substantially restored toward hypertensive-appropriate values, although
the vessel still remains overly-thick relative to the remnant pressure P/Po = 1.15 due to the
persistent inflammation. This partially reversible slow adaptation is possible numerically because
we let the inflammation-dependent parameters for smooth muscle and collagen fibers return
toward normal values in line with the decrease in inflammation. Yet, experimental observations
in [22], as well as associated computations in [21], suggest that even if inflammation has partially
resolved and pressure dropped, the long-term response yet remains markedly maladaptive, with
both thickness and stresses remaining far from the initial homeostatic values. Hence, we also
show results (dashed lines) for a simulation where the computed inflammation decreases during
the long period without AngII infusion (i.e., we maintain the value µ̄−ϕ > 0), which affects the
stimulus functions in Eq. (2.7), but with the smooth muscle and collagen fiber parameters retained
as fully maladaptive (i.e., those associated with ∆%ϕmax), which adversely affect their passive












There are many different models of hypertension in mice, but infusion of AngII has emerged
as one of the most common given its diverse but highly reproducible effects on central
arteries. Importantly, AngII increases total peripheral resistance and thereby elevates central
blood pressure, thus increasing the hemodynamic load on the central arteries; in addition, it
stimulates significant vascular inflammation throughout the vasculature. Macrophages, both
resident and recruited, play key roles in AngII-induced hypertensive aortic remodeling as
evidenced by measurements of cellular infiltration within the aortic wall and especially by
experiments wherein reductions of recruited macrophages or their activity, including via CCR2
receptor disruption, attenuates otherwise marked aortic remodeling [35–37]. Notwithstanding
the tremendous insight gained via such in vivo experiments, the potentially overlapping effects
of increased mechanical loading and stimulation of inflammation makes it difficult to delineate
mechanisms. We know, for example, that increased mechanical loading (stretching/stressing) of
isolated smooth muscle cells and fibroblasts changes gene expression to promote heightened
matrix turnover [30,38], with mechanical stretch similarly able to induce pro-inflammatory
genes in isolated macrophages [39,40]. Conversely, exposure of isolated medial smooth muscle
cells to exogenous AngII stimulates cell production of interleukin-6 (IL-6) whereas exposure
of adventitial fibroblasts to AngII stimulates production of both monocyte chemoattractant
protein-1 (MCP-1), which attracts monocytes, and IL-6, which activates monocytes [41,42].
Exogenous AngII also directly stimulates matrix production by isolated smooth muscle cells
and fibroblasts [43,44], and mechanical loading stimulates local production of AngII by smooth
muscle cells [38,45], which contributes to matrix production (synthesis) and removal (degradation
by MMPs). Importantly, disruption of the α1 integrin subunit disrupts mechano-sensing and
attenuates AngII-induced elastic artery remodeling [46]. Pressure-induced mechanical stress and
exogenous AngII can thus have both separate and synergistic effects on aortic remodeling [47,48],
highlighting the complex interactions amongst mechanical stress and inflammation in driving
matrix turnover.
T-cells similarly play multiple roles in AngII-induced hypertension and associated aortic
remodeling. Among other effects, T-cells accumulate in perivascular fat and to a lesser extent
in the aortic wall following AngII infusion. They increase oxidative stress and contribute to
adventitial fibrosis by stimulating collagen production [49], the latter due in part to production
of interleukin-17a (IL-17a), which has been shown in cell culture to directly stimulate collagen
production by isolated adventitial fibroblasts, which of course also increase collagen production
in response to increased stretch [30]. These T-cells appear to produce interferon gamma (IFN-γ)
and tissue necrosis factor alpha (TNF-α) at a normal rate in AngII-induced hypertension, though
the intramural amounts of these two pro-inflammatory cytokines is greater in hypertension
due to the significant increase in the number of recruited cell [50]. Importantly, it was shown
further that effects of AngII-induced hypertension on T-cells in (humanized) mice was due to
the “hypertensive mileu”and not the direct action of AngII on the T-cells [51], consistent with
the aforementioned concept that inflammation arises in support of homeostasis when primary
homeostatic processes are insufficient to reduce the effects of the perturbation quickly enough
[13]. Notwithstanding the extreme complexities of inflammation in hypertension [52–54], which
are not yet understood fully even for AngII-induced hypertension, it is clear that one must
consider both immuno- and mechano-contributions to the associated aortic remodeling.
This paper was motivated primarily by particular experimental and computational findings
of AngII-induced remodeling of the descending thoracic aorta in male C57BL/6 and Apoe-/- mice
on a C57BL/6 background. We had observed a trend toward mechano-adaption of this segment
of the aorta up to 14 days of high rate AngII infusion, but a remarkable maladaptive response
thereafter that was characterized by a dramatic infiltration of CD45+ cells, including CD3+ T-cells,
and CD68+ macrophages that correlated with a marked accumulation of collagen, especially in
the adventitia. These findings suggested that a mechano-driven remodeling preceded immuno-











perturbation in pressure and is then followed by an inflammatory process is consistent with
the concept put forth by [13] that inflammation can support homeostasis when the primary
restorative mechanisms are insufficient. Yet, in this case, the inflammation drove a maladaptive,
not adaptive, remodeling of the aorta. We later attempted to model this complex aortic response
and found for the first time that gain parameters and set-points within a mechanobiological model
needed to evolve to fit this complex data set [21]. This change in homeostatic parameters is also
consistent with the observation of [15] that, being a prioritized process, inflammation can override
normal homeostatic set-points and gains. Whereas we previously prescribed the time-course of
the inflammation that drove the associated remodeling, here we have introduced a new approach
consistent with the concept of [15] whereby mechanical stress induces chronic inflammation only
if particular thresholds are reached. Remarkably, if stresses do not reach these thresholds, this
approach also allows lower levels of inflammation to emerge to support mechanical homeostasis;
it is therefore consistent, too, with the concept of para-inflammation put forth by [13].
The Laplace equation illustrates well the fundamental role of distending pressure on the value
of mean circumferential wall stress, but it is seldom emphasized that smooth muscle cell tone
plays a similarly fundamental role. That is, if we write this equation as σθθ = Pa (P,C) /h(P,C),
where a and h are luminal radius and wall thickness, respectively, and P andC are the distending
pressure and contractile strength, then it is clear that pressure and smooth muscle tone are equally
important determinants of intramural stress, which we include as a convenient homeostatic target
(actually the first invariant of stress). Accumulating evidence suggests strongly that increased
local smooth muscle contractility dramatically reduces the degree of hypertensive remodeling
[22,32,34]. We thus included the role of smooth muscle tone as a physiological modifier of the
mechanical stress stimulus, and indeed found that increasing smooth muscle tone reduces the
degree of the remodeling response by attenuating the increase in intramural stress due to pressure
elevation. We also found that a sufficiently high level of smooth muscle tone can prevent the
engagement of inflammation despite infusion of the pro-inflammatory peptide AngII, consistent
with differential findings between the non-contractile thoracic and highly contractile abdominal
aorta [22] as well as the finding of reduced inflammation in AngII-induced hypertension in the
presence of blood pressure (and thus intramural stress) lowering drugs [51]. Among other key
predictions, the computationally modeled aorta was better able to respond to the same fold-
increase in pressure for lower rates of pressure elevation. That is, it is easier to adapt to a slower,
progressive increase in pressure than to an abrupt increase, with stress-induced inflammation
playing a key role in the underlying remodeling. This finding is similar to that predicted by purely
mechanobiological models for vein graft remodeling under extreme changes in hemodynamic
conditions [55] and is intuitive given that changes in gene expression and translation into
functional structural modifications of the wall are time-dependent and the cells have finite
limits on their rates of division or production. Hence, it also appropriately extends our previous
analysis of critical roles that different timescales may have on ideal mechano-adaptations [24]
by taking into account alternate, either reversible or overriding, effects of inflammation within
a generally coupled remodeling scenario. It was also found that an initial (para)inflammatory
response contributes to the mechano-adaptation, accelerating the remodeling and helping to
reduce maximal wall stresses for the same perturbation in pressure, hence highlighting a key
contribution of this additional mechanism in promoting homeostasis, especially when purely
mechano-driven turnover mechanisms are unable to respond quickly enough to recover from a
(otherwise mild) perturbation. Finally, it was found that, even if both pressure and inflammation
are partially reversed after several months of recovery without AngII infusion, the mechanical
properties of the newly deposited constituents during this long period need not return to normal
values at the same pace, hence suggesting that the ensuing remodeling depends not only on
the current, persistent level of inflammation but, more generally, on the longer, past history of












In conclusion, it has long been known that the aorta adapts in response to modest
sustained changes in hemodynamic loading via cell and matrix turnover within evolving
configurations. It is becoming increasingly evident that inflammation plays either complementary
or contrasting roles with such mechano-adaptations, with modest inflammation promoting
homeostatic remodeling, but marked or chronic inflammation preventing homeostasis and
driving disease progression. We have introduced the first coupled immuno-mechano model of
aortic remodeling, consistent with new concepts of inflammation as well as data from a common
mouse model of hypertension. As with many other phenomenological models of vascular growth
and remodeling, the present model is descriptive but also predictive; it can be used to generate
and test new hypotheses and to guide experimental design. Nevertheless, there is also a need
for more mechanistic modeling, as, for example, incorporating appropriate cell signaling models
(cf. [56]) within the current continuum framework to enable modeling from transcript to tissue.
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2h 155.7 kPa, 1.2
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Smooth Muscle Tone Tmax 258 kPa
Minimal / Maximal Contraction Stretches λ0, λM 0.6, 1.1
Vasoactive Parameters CB , CS 0.833, 1.666
Rate Parameter kact 1/7 day−1
Mechano-regulated G&R
Medial Collagen Gains KcMσ, K
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, KcM%ϕ 2.00, 2.50, 1.74
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A0 [1/7, 1/7, 1/7] day
−1
Stress-dependent inflammation
Stress Threshold σ∗v 170 kPa
Adaptive Response Gain Kϕ 2.5
Maladaptive Response Parameters µ̄+ϕ , µ̄
−
ϕ 0.102, 0.0008 day
−2
Rate Parameter kϕ 2/7 day−1
Table 1. G&R model parameters for both an original / basal (subscript o; control) and an evolved-to-new homeostatic
(subscript h; AngII infused) state for the descending thoracic aorta (DTA) from wild-type (C57BL/6) mice [20,31].
“Elastin”, “Muscle”, and “Collagen” parameters represent elastin-dominated isotropic and smooth muscle / collagen-
dominated anisotropic contributions, with glycosaminoglycans and other constituents not specified explicitly. Subscripts
M and A refer to medial and adventitial respectively. Smooth muscle and collagen parameters and deposition
stretches evolve from normotensive (adaptive, o) to hypertensive (maladaptive, h) conditions with the extent of the






















Figure 1. Schema of complementary or contrasting roles of mechano- and immuno-regulation in tissue homeostasis,
with potential lost homeostasis in extreme cases. In particular, (A) mechanical homeostasis maintains near normal tissue-
level composition, structure, properties, and function over long periods in health despite continual turnover of many
intramural constituents during transient changes in hemodynamics on a daily basis; (B) mechanical homeostasis can
restore mechano-regulated variables (i.e., states) toward normal following marked perturbations, as, for example, modest
sustained changes in hemodynamics; (C) mechanical and inflammatory processes can work together to restore regulated
variables toward normal, though at times with a resetting of set-points; (D) severe or sustained (chronic) inflammation
can over-ride normal homeostatic processes, thus resulting in maladaptation or additional disease progression, as, for
example, in highly fibrotic responses in some vessels during hypertension. Although particular responses (A-D) are
suggested to define particular ranges, these responses are expected to represent a continuous spectrum. Overall schema











Figure 2. A. Schema of how inflammation influences the turnover of smooth muscle cells and collagen fibers via their
stimulus functions for mass density production, passive mechanical properties, and deposition stretches. B. Typical time
course of µϕ and σ progression. In period I, stress (σ) is below its threshold σ∗, and inflammation contributes to
homeostasis. At time τ1, stress passes its threshold and µϕ starts increasing linearly at a rate µ̄
+
ϕ (period II), until it
saturates at a value kϕ at time τ2. As long as σ≥ σ∗, µϕ remains saturated at a level of kϕ (period III). As soon as σ
drops below σ∗ at time τ3, µϕ starts decreasing linearly at a rate of −µ̄−ϕ (period IV). If, in phase II, σ drops below σ∗
before µϕ reaches kϕ, no plateau in µϕ (no phase III) occurs. See Table 1 or [20] for specific functional dependencies





















































































Figure 3. Different hypertensive remodeling responses predicted by the present coupled stress-driven inflammation G&R
model for different rates of increase in blood pressure over 1 (solid lines) to 3 (dotted lines) weeks, yielding progressively
more adaptive remodeling responses. Shown, too, are mean ± SEM experimental values (open circles with error bars)
extracted from [31], which reports remodeling at two and four weeks given a rapid increase in pressure within about
one week. Note that the temporal profile for pressure P is the only input to the model; all other variables, including the
extent of inflammation ∆%ϕ, are computed (i.e., predicted) as part of the solution of the coupled model. The predictions
match the available experimental data well. Albeit not shown, the in vivo value of axial stretch∼1.7 (normotensive, s= 0)
was predicted to decrease with hypertensive remodeling in all cases; in particular to ∼1.35 (fully maladaptive, solid line)
or ∼1.6 (adaptive, dotted line), consistent with both experimental findings and prior predictions in [20] with prescribed
inflammation. Note for the latter that a slight over-thickening (relative to an ideal mechanoadaptation [29]) combined
with the recovery of the target stress / set-point (i.e., with absent overriding inflammatory effects) to yield a decrease in
circumferential stress and associated increase in axial stress (hence an increase in axial force required to maintain the,
herein assumed fixed, in vivo axial length; not shown). There remains a pressing need for more data on axial behavior,
which are not available during in vivo studies, in order to identify an ideal stimulus function that accounts for differential
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Figure 4. Different hypertensive remodeling responses predicted by the coupled stress-driven inflammation G&R model
for gradual increases in contractile tone Tmax (s) = Tmax (0) (1 +KP (P (s)− P (0))/P (0)) in Eq. (2.12) fromKP =
0 (constant tone, solid lines) toKP = 4 (maximally enhanced tone with hypertension, dotted lines), yielding progressively
more adaptive remodeling responses. Note that the temporal profile for pressure P is the only input to the model; all other
variables, including the extent of inflammation ∆%ϕ, are computed as part of the solution of the coupled model. There














































































Figure 5. Model predictions of long-term responses up to 196 days after terminating the AngII infusion at 28 days following
a 1.36-fold increase in systolic pressure (A, model input) that persists up to s = 28 days but drops to P/Po = 1.15 during
the subsequent 196 days. Predictions are shown with (solid line) and without (dash-dotted) recovery of passive properties
of smooth muscle cells and collagen fibers toward their original homeostatic values with the computed (partial) reversal
of inflammation (L). Shown, too, are mean ± SEM experimental values (open circles with error bars) extracted from [31]
at 28 days and (pre-)assumed values (solid circles with error bars) for the remnant pressure and inflammation at 224
days consistent with [22] and [21]. There is a pressing need for more longitudinal data on potential recovery of vascular
properties following elimination of a prior long-term perturbation.
